Omnicell Past Earnings Performance
Past criteria checks 0/6
Omnicell's earnings have been declining at an average annual rate of -41.4%, while the Medical Equipment industry saw earnings growing at 11.4% annually. Revenues have been growing at an average rate of 7.7% per year.
Key information
-41.4%
Earnings growth rate
-42.1%
EPS growth rate
Medical Equipment Industry Growth | 8.9% |
Revenue growth rate | 7.7% |
Return on equity | -1.7% |
Net Margin | -1.9% |
Last Earnings Update | 30 Jun 2024 |
Recent past performance updates
Recent updates
Omnicell, Inc.'s (NASDAQ:OMCL) Price Is Right But Growth Is Lacking After Shares Rocket 49%
Aug 02Is There Now An Opportunity In Omnicell, Inc. (NASDAQ:OMCL)?
Jul 11Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price
Jun 16Omnicell (NASDAQ:OMCL) Is Making Moderate Use Of Debt
May 25An Intrinsic Calculation For Omnicell, Inc. (NASDAQ:OMCL) Suggests It's 29% Undervalued
Mar 28Omnicell, Inc.'s (NASDAQ:OMCL) 25% Dip In Price Shows Sentiment Is Matching Revenues
Feb 29Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?
Feb 23Omnicell Is Building A Strong Moat
Feb 22Does Omnicell (NASDAQ:OMCL) Have A Healthy Balance Sheet?
Jan 15Benign Growth For Omnicell, Inc. (NASDAQ:OMCL) Underpins Its Share Price
Dec 25Is Omnicell, Inc. (NASDAQ:OMCL) Trading At A 48% Discount?
Dec 06Omnicell, Inc. (NASDAQ:OMCL) Analysts Just Slashed Next Year's Revenue Estimates By 14%
Nov 10Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 27% Undervaluation?
Sep 06Would Omnicell (NASDAQ:OMCL) Be Better Off With Less Debt?
Aug 08Why Omnicell, Inc. (NASDAQ:OMCL) Could Be Worth Watching
Jul 02A Look At The Fair Value Of Omnicell, Inc. (NASDAQ:OMCL)
Jun 08Investors Could Be Concerned With Omnicell's (NASDAQ:OMCL) Returns On Capital
Apr 29Is Omnicell (NASDAQ:OMCL) Using Too Much Debt?
Apr 11At US$55.77, Is Omnicell, Inc. (NASDAQ:OMCL) Worth Looking At Closely?
Mar 23Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 42% Undervaluation?
Feb 28Returns On Capital Are Showing Encouraging Signs At Omnicell (NASDAQ:OMCL)
Jan 15We Think Omnicell (NASDAQ:OMCL) Can Stay On Top Of Its Debt
Jan 01Is There An Opportunity With Omnicell, Inc.'s (NASDAQ:OMCL) 46% Undervaluation?
Nov 17Analysts Just Slashed Their Omnicell, Inc. (NASDAQ:OMCL) EPS Numbers
Nov 03Omnicell launches Specialty Pharmacy Services
Oct 11Omnicell (NASDAQ:OMCL) Seems To Use Debt Quite Sensibly
Sep 30Omnicell says advance services to drive profitable growth in long-run: Investor Day
Sep 20Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?
Sep 15Omnicell (NASDAQ:OMCL) Might Have The Makings Of A Multi-Bagger
Aug 31Omnicell reports Q2 earnings miss; reaffirms FY22 guidance and issues Q3 outlook
Aug 04Are Investors Undervaluing Omnicell, Inc. (NASDAQ:OMCL) By 41%?
Aug 03Omnicell Fails To Justify Inclusion In Long-Only, Equity-Focused Portfolio
Jul 21We Ran A Stock Scan For Earnings Growth And Omnicell (NASDAQ:OMCL) Passed With Ease
Jun 27Is Now An Opportune Moment To Examine Omnicell, Inc. (NASDAQ:OMCL)?
Jun 13Omnicell's (NASDAQ:OMCL) Returns On Capital Are Heading Higher
May 30These 4 Measures Indicate That Omnicell (NASDAQ:OMCL) Is Using Debt Safely
May 05Revenue & Expenses Breakdown
How Omnicell makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
30 Jun 24 | 1,080 | -21 | 395 | 91 |
31 Mar 24 | 1,103 | -21 | 408 | 93 |
31 Dec 23 | 1,147 | -20 | 428 | 93 |
30 Sep 23 | 1,186 | -34 | 454 | 97 |
30 Jun 23 | 1,235 | -23 | 463 | 97 |
31 Mar 23 | 1,268 | -18 | 475 | 101 |
31 Dec 22 | 1,296 | 6 | 479 | 102 |
30 Sep 22 | 1,309 | 48 | 453 | 96 |
30 Jun 22 | 1,258 | 61 | 438 | 91 |
31 Mar 22 | 1,199 | 72 | 412 | 83 |
31 Dec 21 | 1,132 | 78 | 381 | 76 |
30 Sep 21 | 1,070 | 80 | 354 | 69 |
30 Jun 21 | 987 | 60 | 327 | 65 |
31 Mar 21 | 914 | 35 | 306 | 65 |
31 Dec 20 | 892 | 32 | 297 | 66 |
30 Sep 20 | 891 | 38 | 298 | 70 |
30 Jun 20 | 906 | 49 | 298 | 71 |
31 Mar 20 | 924 | 69 | 298 | 70 |
31 Dec 19 | 897 | 61 | 290 | 69 |
30 Sep 19 | 860 | 54 | 274 | 67 |
30 Jun 19 | 836 | 48 | 269 | 66 |
31 Mar 19 | 807 | 38 | 266 | 64 |
31 Dec 18 | 787 | 38 | 259 | 65 |
30 Sep 18 | 772 | 54 | 258 | 64 |
30 Jun 18 | 754 | 48 | 249 | 64 |
31 Mar 18 | 747 | 44 | 245 | 67 |
31 Dec 17 | 713 | 31 | 241 | 66 |
30 Sep 17 | 688 | -1 | 233 | 65 |
30 Jun 17 | 678 | -6 | 238 | 64 |
31 Mar 17 | 670 | -9 | 243 | 60 |
31 Dec 16 | 696 | 10 | 230 | 58 |
30 Sep 16 | 651 | 8 | 231 | 52 |
30 Jun 16 | 599 | 14 | 210 | 46 |
31 Mar 16 | 539 | 24 | 184 | 41 |
31 Dec 15 | 485 | 31 | 165 | 35 |
30 Sep 15 | 476 | 32 | 166 | 34 |
30 Jun 15 | 463 | 32 | 164 | 32 |
31 Mar 15 | 455 | 31 | 161 | 30 |
31 Dec 14 | 441 | 31 | 156 | 28 |
30 Sep 14 | 425 | 28 | 149 | 27 |
30 Jun 14 | 407 | 29 | 145 | 26 |
31 Mar 14 | 395 | 27 | 141 | 27 |
31 Dec 13 | 381 | 24 | 139 | 27 |
30 Sep 13 | 365 | 23 | 135 | 26 |
Quality Earnings: OMCL is currently unprofitable.
Growing Profit Margin: OMCL is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: OMCL is unprofitable, and losses have increased over the past 5 years at a rate of 41.4% per year.
Accelerating Growth: Unable to compare OMCL's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: OMCL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (7.2%).
Return on Equity
High ROE: OMCL has a negative Return on Equity (-1.73%), as it is currently unprofitable.